FEEDBACK PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85 GBX | +3.03% |
|
+3.03% | +25.93% |
| Mar. 25 | Feedback shares skyrocket on partnership for TB screening in India | AN |
| Mar. 25 | Feedback plc, Heal Foundation Team Up for Tuberculosis Screening Projects in India | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1.5M 1.87M | Sales 2025 * | 2.2M 2.75M | Capitalization | 11M 13.74M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 5.61 x |
| Net cash position 2024 * | 2.59M 3.23M | Net Debt 2025 * | 1.63M 2.04M | EV / Sales 2025 * | 5.74 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 24 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.96% |
More Fundamentals
* Assessed data
More news
Latest transcript on Feedback plc
More press releases
| 1 day | +3.03% | ||
| 1 week | +3.03% | ||
| Current month | -5.56% | ||
| 1 month | -34.62% | ||
| 3 months | +37.10% | ||
| 6 months | +6.25% | ||
| Current year | +25.93% |
1 week
80.15
85.00
1 month
80.15125.00
Current year
55.00152.92
1 year
55.00152.92
3 years
55.00274.80
5 years
55.00483.90
10 years
55.001 040.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 36 | 19-04-08 | |
Aneshkumar Patel
DFI | Director of Finance/CFO | 43 | 21-11-28 |
Stephen McAteer
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 20-07-14 | |
| Chairman | 70 | 19-08-28 | |
| Chief Executive Officer | 36 | 19-04-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 85 | +3.03% | 1 |
| 24-05-07 | 82.5 | 0.00% | 12,745 |
| 24-05-03 | 82.5 | 0.00% | 10,130 |
| 24-05-02 | 82.5 | 0.00% | 5,234 |
| 24-05-01 | 82.5 | -8.33% | 20,162 |
Delayed Quote London S.E., May 08, 2024 at 05:21 am EDT
More quotes
Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is a clinician facing platform that displays clinical results from a patient's CareLocker at a certified and regulated quality, that is suitable for clinical use and enables dialogue on a patient-by-patient basis with colleagues through a secure, auditable chat interface that links back to the patient medical record. The CareLocker data storage model is built around the patient. The Company has a number of growth opportunities domestically and internationally across a range of markets.
Calendar
2024-10-23
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.825
GBP
Average target price
2.4
GBP
Spread / Average Target
+190.91%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +25.93% | 13.8M | |
| +6.64% | 33.18B | |
| +21.35% | 7.81B | |
| +23.04% | 3.98B | |
| -16.41% | 3.17B | |
| -19.48% | 1.39B | |
| -30.77% | 1.2B | |
| +8.47% | 970M | |
| -32.21% | 950M | |
| -28.36% | 808M |
- Stock Market
- Equities
- FDBK Stock